Seroprevalence of Dengue and Zika Virus in Blood Donations: A Systematic Review

Stephanie M. Eick, Ariella Perry Dale, Brian McKay, Casey Lawrence, Mark H. Ebell, José F. Cordero, Michael Welton

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The presence of antibodies to Zika virus (ZIKV) and dengue virus (DENV) can be detected in blood donations. Donation-based surveillance provides an alternative strategy to estimate population prevalence by detecting antibodies that are circulating. To estimate population prevalence, we conducted a systematic review of literature on the seroprevalence of ZIKV and DENV antibodies in blood donations. We searched PubMed and Web of Science for studies that reported the seroprevalence of ZIKV and DENV in blood donations. The title and abstract of each study were screened by 2 reviewers simultaneously for possible inclusion, and the full text of selected studies was reviewed to ensure that they met inclusion criteria (used primary data collection, reported evidence of immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in the blood supply, and included a representative sample of the total population). Immunoglobin test measuring levels of antibodies to IgM and IgG and number of positive cases were extracted from each study. No exclusions were made based on language or country. Our initial search identified 1890 studies after excluding duplicates, of which 76 were assessed for full text eligibility to ensure that they met our final inclusion criteria. There were 14 studies included in our review; 11 examined the seroprevalence of DENV, and 3 examined ZIKV. The highest seroprevalence by IgM was 2.82% for DENV and 0.53% for ZIKV. Our results indicate that the seroprevalence of ZIKV and DENV antibody presence in countries with active transmission is higher than reports by traditional surveillance in some countries. This finding is expected due to the large percentage of asymptomatic cases. The highest seroprevalence was observed for IgG, which can persist over long periods of time compared to IgM. Screening of blood donations may help supplement traditional surveillance measures, especially during outbreak settings.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalTransfusion Medicine Reviews
Volume33
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Dengue Virus
Seroepidemiologic Studies
Blood Donors
Viruses
Blood
Immunoglobulin M
Antibodies
Immunoglobulin G
Population
PubMed
Disease Outbreaks
Zika Virus
Language
Screening

Keywords

  • Blood donations
  • Blood supply
  • Dengue virus
  • Surveillance
  • Transmission
  • Zika virus

ASJC Scopus subject areas

  • Hematology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Eick, S. M., Dale, A. P., McKay, B., Lawrence, C., Ebell, M. H., Cordero, J. F., & Welton, M. (2019). Seroprevalence of Dengue and Zika Virus in Blood Donations: A Systematic Review. Transfusion Medicine Reviews, 33(1), 35-42. https://doi.org/10.1016/j.tmrv.2018.10.001

Seroprevalence of Dengue and Zika Virus in Blood Donations : A Systematic Review. / Eick, Stephanie M.; Dale, Ariella Perry; McKay, Brian; Lawrence, Casey; Ebell, Mark H.; Cordero, José F.; Welton, Michael.

In: Transfusion Medicine Reviews, Vol. 33, No. 1, 01.01.2019, p. 35-42.

Research output: Contribution to journalReview article

Eick, SM, Dale, AP, McKay, B, Lawrence, C, Ebell, MH, Cordero, JF & Welton, M 2019, 'Seroprevalence of Dengue and Zika Virus in Blood Donations: A Systematic Review', Transfusion Medicine Reviews, vol. 33, no. 1, pp. 35-42. https://doi.org/10.1016/j.tmrv.2018.10.001
Eick, Stephanie M. ; Dale, Ariella Perry ; McKay, Brian ; Lawrence, Casey ; Ebell, Mark H. ; Cordero, José F. ; Welton, Michael. / Seroprevalence of Dengue and Zika Virus in Blood Donations : A Systematic Review. In: Transfusion Medicine Reviews. 2019 ; Vol. 33, No. 1. pp. 35-42.
@article{15e5dc03af86455cb70de250d908a11c,
title = "Seroprevalence of Dengue and Zika Virus in Blood Donations: A Systematic Review",
abstract = "The presence of antibodies to Zika virus (ZIKV) and dengue virus (DENV) can be detected in blood donations. Donation-based surveillance provides an alternative strategy to estimate population prevalence by detecting antibodies that are circulating. To estimate population prevalence, we conducted a systematic review of literature on the seroprevalence of ZIKV and DENV antibodies in blood donations. We searched PubMed and Web of Science for studies that reported the seroprevalence of ZIKV and DENV in blood donations. The title and abstract of each study were screened by 2 reviewers simultaneously for possible inclusion, and the full text of selected studies was reviewed to ensure that they met inclusion criteria (used primary data collection, reported evidence of immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in the blood supply, and included a representative sample of the total population). Immunoglobin test measuring levels of antibodies to IgM and IgG and number of positive cases were extracted from each study. No exclusions were made based on language or country. Our initial search identified 1890 studies after excluding duplicates, of which 76 were assessed for full text eligibility to ensure that they met our final inclusion criteria. There were 14 studies included in our review; 11 examined the seroprevalence of DENV, and 3 examined ZIKV. The highest seroprevalence by IgM was 2.82{\%} for DENV and 0.53{\%} for ZIKV. Our results indicate that the seroprevalence of ZIKV and DENV antibody presence in countries with active transmission is higher than reports by traditional surveillance in some countries. This finding is expected due to the large percentage of asymptomatic cases. The highest seroprevalence was observed for IgG, which can persist over long periods of time compared to IgM. Screening of blood donations may help supplement traditional surveillance measures, especially during outbreak settings.",
keywords = "Blood donations, Blood supply, Dengue virus, Surveillance, Transmission, Zika virus",
author = "Eick, {Stephanie M.} and Dale, {Ariella Perry} and Brian McKay and Casey Lawrence and Ebell, {Mark H.} and Cordero, {Jos{\'e} F.} and Michael Welton",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.tmrv.2018.10.001",
language = "English (US)",
volume = "33",
pages = "35--42",
journal = "Transfusion Medicine Reviews",
issn = "0887-7963",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Seroprevalence of Dengue and Zika Virus in Blood Donations

T2 - A Systematic Review

AU - Eick, Stephanie M.

AU - Dale, Ariella Perry

AU - McKay, Brian

AU - Lawrence, Casey

AU - Ebell, Mark H.

AU - Cordero, José F.

AU - Welton, Michael

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The presence of antibodies to Zika virus (ZIKV) and dengue virus (DENV) can be detected in blood donations. Donation-based surveillance provides an alternative strategy to estimate population prevalence by detecting antibodies that are circulating. To estimate population prevalence, we conducted a systematic review of literature on the seroprevalence of ZIKV and DENV antibodies in blood donations. We searched PubMed and Web of Science for studies that reported the seroprevalence of ZIKV and DENV in blood donations. The title and abstract of each study were screened by 2 reviewers simultaneously for possible inclusion, and the full text of selected studies was reviewed to ensure that they met inclusion criteria (used primary data collection, reported evidence of immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in the blood supply, and included a representative sample of the total population). Immunoglobin test measuring levels of antibodies to IgM and IgG and number of positive cases were extracted from each study. No exclusions were made based on language or country. Our initial search identified 1890 studies after excluding duplicates, of which 76 were assessed for full text eligibility to ensure that they met our final inclusion criteria. There were 14 studies included in our review; 11 examined the seroprevalence of DENV, and 3 examined ZIKV. The highest seroprevalence by IgM was 2.82% for DENV and 0.53% for ZIKV. Our results indicate that the seroprevalence of ZIKV and DENV antibody presence in countries with active transmission is higher than reports by traditional surveillance in some countries. This finding is expected due to the large percentage of asymptomatic cases. The highest seroprevalence was observed for IgG, which can persist over long periods of time compared to IgM. Screening of blood donations may help supplement traditional surveillance measures, especially during outbreak settings.

AB - The presence of antibodies to Zika virus (ZIKV) and dengue virus (DENV) can be detected in blood donations. Donation-based surveillance provides an alternative strategy to estimate population prevalence by detecting antibodies that are circulating. To estimate population prevalence, we conducted a systematic review of literature on the seroprevalence of ZIKV and DENV antibodies in blood donations. We searched PubMed and Web of Science for studies that reported the seroprevalence of ZIKV and DENV in blood donations. The title and abstract of each study were screened by 2 reviewers simultaneously for possible inclusion, and the full text of selected studies was reviewed to ensure that they met inclusion criteria (used primary data collection, reported evidence of immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in the blood supply, and included a representative sample of the total population). Immunoglobin test measuring levels of antibodies to IgM and IgG and number of positive cases were extracted from each study. No exclusions were made based on language or country. Our initial search identified 1890 studies after excluding duplicates, of which 76 were assessed for full text eligibility to ensure that they met our final inclusion criteria. There were 14 studies included in our review; 11 examined the seroprevalence of DENV, and 3 examined ZIKV. The highest seroprevalence by IgM was 2.82% for DENV and 0.53% for ZIKV. Our results indicate that the seroprevalence of ZIKV and DENV antibody presence in countries with active transmission is higher than reports by traditional surveillance in some countries. This finding is expected due to the large percentage of asymptomatic cases. The highest seroprevalence was observed for IgG, which can persist over long periods of time compared to IgM. Screening of blood donations may help supplement traditional surveillance measures, especially during outbreak settings.

KW - Blood donations

KW - Blood supply

KW - Dengue virus

KW - Surveillance

KW - Transmission

KW - Zika virus

UR - http://www.scopus.com/inward/record.url?scp=85056988852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056988852&partnerID=8YFLogxK

U2 - 10.1016/j.tmrv.2018.10.001

DO - 10.1016/j.tmrv.2018.10.001

M3 - Review article

C2 - 30471867

AN - SCOPUS:85056988852

VL - 33

SP - 35

EP - 42

JO - Transfusion Medicine Reviews

JF - Transfusion Medicine Reviews

SN - 0887-7963

IS - 1

ER -